A phase 1 study investigating DX-2930 in healthy subjects
Yung Chyung(Massachusetts General Hospital), Burt Adelman(Unknown), Ryan Iarrobino(Massachusetts General Hospital), Bradley Vince(Altasciences Clinical Research Vince & Associates), Leslie E. Stolz(Eli Lilly (Netherlands)), Joseph C. Biedenkapp(Massachusetts General Hospital), Dan Sexton(Takeda (United States)), Chris Stevens(Massachusetts General Hospital), Ryan Faucette(Massachusetts General Hospital), Chris TenHoor(Takeda (United States)), Jon Kenniston(Massachusetts General Hospital)
Cited by 60
Related Papers
Treatment with Bivalirudin (Hirulog) as Compared with Heparin during Coronary Angioplasty for Unstable or Postinfarction Angina
|New England Journal of Medicine|1995|496
Peroxisome Proliferator Activator Receptor γ Coactivator-1 Expression Is Reduced in Obesity
|Journal of Biological Chemistry|2007|235
Randomized, Double-blind Comparison of Hirulog Versus Heparin in Patients Receiving Streptokinase and Aspirin for Acute Myocardial Infarction (HERO)
|Circulation|1997|232
Synthesis of basement membrane collagen by cultured human endothelial cells.
|The Journal of Experimental Medicine|1976|208
Analysis of shear stress and hemodynamic factors in a model of coronary artery stenosis and thrombosis
|American Journal of Physiology-Heart and Circulatory Physiology|1993|202